Uncategorized

By David Tuller, DrPH David Tuller is academic coordinator of the concurrent masters degree program in public health and journalism at the University of California, Berkeley.   The PACE authors have long demonstrated great facility in evading questions they don’t want to answer. They did this in their response to correspondence about the original 2011 Lancet paper. …

Trial By Error, Continued: More Nonsense from The Lancet Psychiatry Read More »

By Julie Rehmeyer and David Tuller, DrPH Julie Rehmeyer is a journalist and Ted Scripps Environmental Journalism Fellow at the University of Colorado, Boulder, who has written extensively about ME/CFS. David Tuller is academic coordinator of the concurrent masters degree program in public health and journalism at the University of California, Berkeley. Joining me for this episode of our ongoing saga …

Trial By Error, Continued: Did the PACE Trial Really Prove that Graded Exercise Is Safe? Read More »

By David Tuller, DrPH David Tuller is academic coordinator of the concurrent masters degree program in public health and journalism at the University of California, Berkeley. I have been seeking answers from the PACE researchers for more than a year. At the end of this post, I have included the list of questions I’d compiled …

Trial By Error, Continued: Questions for Dr. White and his PACE Colleagues Read More »

On October 23rd, virology blog published the third installment of David Tuller’s investigative report about the PACE study of treatments for ME/CFS. In the post, Dr. Tuller demonstrated that the key finding of an economic analysis of the PACE trial, published in PLoS One in 2012, was almost certainly false. The finding–that cognitive behavior therapy …

Revisiting the PLoS One economics analysis of PACE Read More »

Mr. Paul Smallcombe Records & Information Compliance Manager Queen Mary University of London Mile End Road London E1 4NS Dear Mr Smallcombe: The PACE study of treatments for ME/CFS has been the source of much controversy since the first results were published in The Lancet in 2011. Patients have repeatedly raised objections to the study’s methodology and …

A request for data from the PACE trial Read More »

A study on the potential of SARS-virus-like bat coronaviruses to cause human disease has reawakened the debate on the risks and benefits of engineering viruses. Let’s go over the science and then see if any of the criticisms have merit. The SARS epidemic of 2003 was caused by a novel coronavirus (CoV) that originated in …

Bat SARS-like coronavirus: It’s not SARS 2.0! Read More »